Within the same tissue location, PGE2 receptor EP2 was upregulated in microglia, resulting in overall higher levels of EP2 in MS lesions compared to NNCs, whereas EP4 decreased in MS lesions. Here, PTGER4 is linked to myeloid sarcoma.